Automated spinal-lesion measurements retain an association with neurological recovery
Source check: Source checked. Not independent scientific confirmation.
Finding: Deep-learning segmentation enabled automatic MRI lesion measurements in 83 spinal-cord injury patients from eight sites. In the observed cohort, lesion width and preserved tissue bridges separated groups with different six-month recovery profiles. These are exploratory within-cohort associations, with no independently validated patient-level prognostic rule or treatment effect.
Technology: SCIsegV2 deep-learning segmentation; conditional-inference tree stratification
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- SCIsegV2 learned image segmentation supplied lesion and spinal-cord masks for automatic morphometrics; learned conditional-inference trees then identified imaging-defined subgroups associated with observed neurological outcomes.
- Test and result
- Retrospective eight-site study of 83 patients with clinical MRI and longitudinal neurological assessments. SCIsegV2 automatically segmented lesion and cord masks; geometric processing produced lesion length, width and tissue-bridge measures. Automatic/manual measures correlated at rho 0.540–0.821. Conditional-inference trees fit to 75 six-month outcomes selected lesion width and, for motor subgroups, tissue-bridge width; subsequent longitudinal models described different observed recovery profiles.
- Limitation / still unknown
- Outcome-derived thresholds and trajectory comparisons use the same cohort, not an untouched external prognostic test. Segmentation errors, partial-volume effects and imaging timing affect very small bridge estimates. Overlap with prior segmenter development was not independently reconciled; no held-out segmentation validation is claimed. Missing outcomes and heterogeneous care/rehabilitation may confound associations. The study does not establish causal tissue mechanisms, deployable cut-offs or improved treatment.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13739854/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Read actual primary named segmenter/automatic-measurement operation, clinical cohort/reference, conditional-inference and longitudinal-model Methods, prognostic-association Results and limitations. Prior segmenter training datasets and supplementary code were not independently inspected; no independent validation is inferred. Exact primary identity/date and fresh primary PubMed correction/retraction relationships checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.